Navigation Links
Nuvelo Announces Publication of Phase 2 rNAPc2 Study Results in,Journal of American College of Cardiology

SAN CARLOS, Calif., June 19, 2007 /PRNewswire-FirstCall/ -- Nuvelo, Inc. today announced the publication of the Phase 2 proof-of-concept data from the Anthem (Anticoagulation with rNAPc2 To Help Eliminate MACE)/TIMI 32 clinical trial (N=255) in the June 26th issue of the Journal of of Cardiology (JACC), demonstrating that higher-dose (greater than or equal to 7.5 mcg/kg) recombinant nematode anticoagulant protein c2 (rNAPc2) reduced the incidence and duration of ischemia as measured by 7-day continuous electrocardiogram (ECG) by more than 50% and did not statistically significantly increase bleeding in patients being treated with standard antithrombotics and an early invasive approach for non-ST-elevation acute coronary syndromes (NSTE-ACS).

"In clinical studies of other antithrombotics, suppression of ischemia monitored by continuous ECG has been associated with a reduction in clinical ischemic events," said Dr. Robert Giugliano, M.D., S.M., Investigator, TIMI Study Group, Associate Physician, Brigham and Women's Hospital and Assistant Professor of Medicine, Harvard Medical School. "In the ANTHEM/TIMI 32 trial, the ability of higher-dose rNAPc2 to reduce ischemia in patients that are already receiving antithrombotic therapy is very exciting, and we look forward to future studies to further understand rNAPc2's potential in this patient population."

ANTHEM/TIMI 32 Study Details and Results

The ANTHEM/TIMI 32 trial consisted of two stages, a dose escalation safety stage and a heparin replacement stage. All patients in the study had 3-lead Holter monitors for assessment of cardiac ischemia, measurement of prothrombin time and F1+2 concentration, and clinical follow-up for up to six months.

The first stage was a double-blind, placebo-controlled, dose escalation study which investigated the safety of rNAPc2 in combination with other antithrombotics in 203 patients with NSTE-ACS. These dat
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Nuvelo Announces Presentations on rNAPc2 and NU172 at the XXIst Congress of the International Society on Thrombosis and Haemostasis
2. Nuvelo Announces Publication of Preclinical Study Results Demonstrating the Potential of NTB-A as a New Target for Leukemia and Lymphomas
3. Nuvelo Announces Publication of NU206 Study Results in Gastroenterology
4. Nuvelo Announces Presentation on NU206 at 2007 American Association for Cancer Research Annual Meeting
5. Nuvelo Announces Presentation on rNAPc2 at American College of Cardiology 56th Annual Scientific Session
6. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
7. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
9. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
10. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
11. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
Post Your Comments:
(Date:9/22/2014)... -- Sutro Biopharma today announced that it has been named ... 15 biotechnology companies, designating it as one of the ... "Sutro has earned some careful attention from ... partners for what promises to be a next-gen approach ... Carroll , editor of FierceBiotech .  "This is ...
(Date:9/22/2014)... 2014 Arena Pharmaceuticals, Inc. (NASDAQ: ... present a corporate overview and update at the NewsMakers ... 2014, at 11:30 a.m. Eastern Time (8:30 a.m. Pacific ... New York City . A live ... the investor relations section of Arena,s website at ...
(Date:9/22/2014)... YORK , Sept. 22, 2014 ... exclusive, global license agreement with Plasma Technologies LLC ... proprietary plasma fractionation process. Concurrently, the Company announced ... to strategically refocus and rebrand the company as ... a national listing for its common shares. ...
Breaking Medicine Technology:FierceBiotech names Sutro Biopharma as one of its "Fierce 15" Biotech Companies of 2014 2FierceBiotech names Sutro Biopharma as one of its "Fierce 15" Biotech Companies of 2014 3Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 2Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 3Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 2Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 3Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 4Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 5Access Pharmaceuticals Announces Exclusive Global Plasma Therapeutics License, New Management And New Corporate Name 6
... , SEATTLE , Feb. 11 ... systems, today announced record 2009 sales results. The successful launch ... growth in excess of 75% and the company,s first cash ... consumed the company,s manufacturing capacity for 2009 and well into ...
... DENVER , Feb. 11 Corgenix Medical Corporation ... test kits, today filed its 2nd quarter Form 10-Q and reported ... declined during the quarter but slightly increased for the six months ... by the report are as follows: , Revenues for the ...
Cached Medicine Technology:Amnis Announces Record 2009 Sales 2Corgenix Reports Second Quarter Fiscal 2010 Financial Results 2Corgenix Reports Second Quarter Fiscal 2010 Financial Results 3Corgenix Reports Second Quarter Fiscal 2010 Financial Results 4
(Date:9/22/2014)... The Gesundheit! Institute founded by Patch ... restructuring for their existing website. The Institute had outgrown their ... way to navigate to the different branches of the organization ... look and feel of the site in a more fun ... Adams graduated from The Medical School of Virginia, he began ...
(Date:9/22/2014)... September 23, 2014 Career Step, ... training, will be attending and exhibiting at the ... Health Information Management Association (AHIMA) in San Diego, ... through October 1, and Career Step will be ... suite of coding training products, including CLiMâ„¢, its ...
(Date:9/22/2014)... Portland, Oregon (PRWEB) September 22, 2014 ... Convention, key leaders from the Oregon long-term care and ... go the extra mile for the well-being of others. ... Operations for Avamere Health Services, will be awarded the ... year by OHCA staff to members who assist OHCA ...
(Date:9/22/2014)... On Saturday, September 27, UHY LLP and UHY ... that is doing an amazing job helping kids and refurbishing ... families and friends will be spending the day at Academy ... and graphics, as well as clean the playground and surrounding ... occur in May but due to weather conditions it was ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 Locating the ... industry is now easier using the Quotes Pros portal ... trying to local universal life insurance pricing from different ... coverage plans that are easily viewed when using the ... specific lengths of coverage. The plan data can be ...
Breaking Medicine News(10 mins):Health News:Idea Marketing Group Launches a New Website for The Gesundheit! Institute 2Health News:Idea Marketing Group Launches a New Website for The Gesundheit! Institute 3Health News:Career Step to Exhibit at AHIMA Convention September 27 through October 1 2Health News:Avamere Family of Companies Regional Director Nominated for the Oregon Health Care Association 2014 Special Service Award 2Health News:Local CPA Firm Gears Up To Revamp Detroit Elementary School Playground 2Health News:Local CPA Firm Gears Up To Revamp Detroit Elementary School Playground 3Health News:Universal Life Insurance Prices for Adults Added to National Insurer Portal Online 2
... ... ... , ... , , , ...
... ... ... ... ...
... Tiny bits of molecular "trash" found in circulating blood ... untimely death, say researchers at Duke University Medical Center. ... issue of the journal Circulation Genetics , comes ... disease, and is the first to identify specific metabolic ...
... tests with rats, tea consumption reduced oxidative stress, researchers say ... green tea work their way into the tissues of the ... researchers say. , The findings, published in the current ... , suggest that the substances, known as catechins, are absorbed ...
... could work, but application remains years away , FRIDAY, Feb. ... first to hint that gene therapy could become a weapon ... remains far from being ready for use by patients, and ... is "a step in the direction of using gene therapy" ...
... ... , ... ... TROY, Mich. , Feb. 19 Joseph F. Page will be a guest speaker at the University of Michigan on ...
Cached Medicine News:Health News:RetireSafe Survey Says Seniors Are Struggling With Increased Costs Without an Increased Social Security Cost of Living Adjustment 2Health News:RetireSafe Survey Says Seniors Are Struggling With Increased Costs Without an Increased Social Security Cost of Living Adjustment 3Health News:Cunard's Queen Victoria is 'Pretty in Pink' in Sydney 2Health News:Tiny molecules may tell big story about cardiovascular disease risk 2Health News:Tiny molecules may tell big story about cardiovascular disease risk 3Health News:Gene Therapy Shows Promise Against HIV 2Health News:Giarmarco, Mullins & Horton, P.C. President Joseph F. Page to Speak at University of Michigan 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: